The global immunoassay market is projected to reach USD 39.0 billion by 2026 from USD 28.4 billion in 2021, at a CAGR of 6.6%

during the forecast period. Market growth is largely driven by the rising incidence of chronic and infectious diseases, technological advancements of immunoassay products, and their massive adoptions… Read full article

Leave a comment

Your email address will not be published. Required fields are marked *